|
Volumn 507, Issue 7493, 2014, Pages 423-425
|
Make mouse studies work
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG EFFECT;
DRUG SCREENING;
INVESTMENT;
MOUSE;
MOUSE MODEL;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
TRANSLATIONAL RESEARCH;
AMYOTROPHIC LATERAL SCLEROSIS;
ANIMAL;
ANTIBODY SPECIFICITY;
ARTICLE;
CAUSE OF DEATH;
CLINICAL TRIAL (TOPIC);
DISEASE COURSE;
DISEASE MODEL;
DOSE RESPONSE;
ECONOMICS;
GENETICS;
HALF LIFE TIME;
HUMAN;
LABORATORY DIAGNOSIS;
METABOLISM;
METHODOLOGY;
PATHOLOGY;
PRACTICE GUIDELINE;
REPRODUCIBILITY;
STANDARD;
SURVIVAL;
TREATMENT FAILURE;
COPPER ZINC SUPEROXIDE DISMUTASE;
SUPEROXIDE DISMUTASE;
AMYOTROPHIC LATERAL SCLEROSIS;
ANIMALS;
CAUSE OF DEATH;
CLINICAL TRIALS AS TOPIC;
DISEASE MODELS, ANIMAL;
DISEASE PROGRESSION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG EVALUATION, PRECLINICAL;
FALSE POSITIVE REACTIONS;
GUIDELINES AS TOPIC;
HALF-LIFE;
HUMANS;
MICE;
ORGAN SPECIFICITY;
REPRODUCIBILITY OF RESULTS;
RESEARCH DESIGN;
SUPEROXIDE DISMUTASE;
SURVIVAL ANALYSIS;
TRANSLATIONAL MEDICAL RESEARCH;
TREATMENT FAILURE;
|
EID: 84897425769
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/507423a Document Type: Note |
Times cited : (510)
|
References (13)
|